Safety and Efficacy of the Surpass Evolve Flow Diverter in Treating Intracranial Aneurysms

Yibin Fang

Status: Active, not recruiting

Conditions: Intracranial Arterial Aneurysm

Treatments: Device: Flow diverting

Study type: Observational

Funder types: Other

Identifiers

NCT06731946

SYNXG202401

Details and patient eligibility

About

Safety and Efficacy of the Surpass Evolve Flow Diverter in Treating Intracranial Aneurysms

Full description

This study aims to retrospectively evaluate the efficacy and safety of the Surpass Evolve Flow Diverter in treating complex intracranial aneurysms. It seeks to assess long-term outcomes and complication rates while analyzing the impact of patient characteristics and aneurysm types on treatment effectiveness. By collecting data from multiple centers, the study ensures broad representativeness, ultimately providing valuable insights for clinical management on a global scale.

Enrollment: 150 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age ≥ 18 years with a confirmed diagnosis of intracranial aneurysm.
2. Imaging studies confirming suitability for Surpass Evolve Flow Diverter treatment.
3. Aneurysms meeting flow diverter treatment indications (e.g., aneurysms larger than 4 mm).
4. At least six months of follow-up data available post-treatment.

Exclusion criteria

1. Patients with acutely ruptured aneurysms or significant bleeding.
2. Patients with incomplete data or insufficient follow-up records.

Trial design

150 participants in 1 patient group

Surpass Evolve Flow Diverter

Treatment:

Device: Flow diverting